*You must be registered for the ANA2021 Virtual Annual Meeting to access the live SIG Series sessions.

Date/Time ET: Wednesday, December 8, 2021 - 11:30 AM  – 1:00 PM

Description: This special interest group session will focus on two areas of contemporary interest in neuromuscular disease. One session will review familial amyloid polyneuropathy and examine the recent development and release of several novel therapies that improve the natural history of this disorder. Another session will review the expanding number of recognized autoantibodies in myositis and discuss the implications for diagnosis and treatment in this heterogeneous group of autoimmune diseases. Three short presentations have been selected from the best accepted neuromuscular abstracts.

Chair: Vern Juel, MD, Duke University

Co-Chair: Michelle Mauermann, MD, Mayo Clinic

Objective(s):

• Recognize the clinical features of familial amyloid polyneuropathy
• Give examples of contemporary treatments for familial amyloid polyneuropathy
• Recognize the limitations of treatments for familial amyloid polyneuropathy
• Identify common myositis autoantibodies
• Describe treatment strategies for distinct autoimmune myopathy syndromes

Presentations:

Therapeutic Advances in Hereditary Transthyretin Amyloid Polyneuropathy

Speaker:

Michelle Mauermann, MD

Mayo Clinic

Myositis Immunology and Autoantibodies

Speaker:

Andrew Mammen, MD, PhD

National Institutes of Health

Neurotoxic Properties of Human Endogenous Retrovirus-k Envelope Protein and Detection in CSF of Patients with ALS

Oral Presenter:

Avindra Nath, MD

National Institutes of Health

Geographical Variation in Proportion of MuSK Antibody Myasthenia Gravis Around the World – A Multicenter Study

Oral Presenter:

Angela Vincent, MBBS

University of Oxford

NADPH Oxidase 5: A New Player in Peripheral Neuropathy

Oral Presenter:

Stephanie Eid, PhD

University of Michigan

 

Continuing Medical Education

The American Neurological Association hosts a wide range of educational programs. These programs seek to enhance the development and success of those pursuing a career in academic neurology at all levels. There are educational offerings to benefit those at the beginning stages of their careers, including students and those in their first faculty position, as well as those looking for best practices in Chair level positions. These programs seek to enhance attendee success in the field of academic neurology and to contribute to the overall education of neurologists and neuroscientists.

The Special Interest Groups offer CME to eligible participants. Click here to see a complete breakdown of how many credits are available per session.

ACCME Accreditation, AMA Designation, and MIPS Statements **Pertaining to Each Session Awarding CME**

The American Neurological Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Neurological Association designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS).

 

Instructions For Obtaining CME

Following the event, the evaluation and credit claiming system will open in OnDEC. Please complete the online evaluation by 12/31/2021 to obtain CME credit. You will be provided with a certificate after completing the evaluation. If you have any questions, please contact the ANA Meeting Coordinator at: meetings@myana.org. 

Click here to see a complete breakdown of how many credits are available per session.

Financial Disclosure Statements

The planners and faculty for this activity do not have any relationships to disclose unless listed here. Any relevant relationships with ACCME-defined ineligible companies will be mitigated according to ACCME Standards prior to the start of the activity.

Disclosure of Commercial Support

ANA received educational grants from the following ACCME-defined ineligible companies to support the CME aspects of this event: Added as confirmed.

DISCLAIMER: The ANA does not endorse or affiliate with third-party companies, products or services including those that may have elected to support the Special Interest Groups.